{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:34:25Z","timestamp":1754397265045},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2009,12,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An asymptomatic 11 weeks old received no treatment after he was classified as having a suspected atypical form of <jats:italic>MYCN<\/jats:italic>\u2010nonamplified hyperdiploid stage 4S neuroblastoma (NB), with masses in an adrenal gland, subcutaneous tissues, and the falx cerebri. Within 2 months, however, disease progressed in dura and bone marrow. Two cycles of low\u2010dose chemotherapy achieved a partial response; treatment was discontinued. Complete remission was documented 24 weeks post\u2010cycle 2, and has continued &gt;6 years. The falx cerebri probably does not represent an atypical site for stage 4S NB, but stage 4 NB with favorable biology is sometimes curable with minimal therapy. Pediatr Blood Cancer 2009; 53:1340\u20131342. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/pbc.22243","type":"journal-article","created":{"date-parts":[[2009,8,27]],"date-time":"2009-08-27T03:45:15Z","timestamp":1251344715000},"page":"1340-1342","source":"Crossref","is-referenced-by-count":2,"title":["A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy"],"prefix":"10.1002","volume":"53","author":[{"given":"Brian H.","family":"Kushner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakeel","family":"Modak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy J.","family":"Akhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nai\u2010Kong V.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.6.1260"},{"key":"e_1_2_4_3_2","first-page":"527s","article-title":"A phase III trial of biologically\u2010based therapy for intermediate risk neuroblastoma","volume":"25","author":"Baker DL","year":"2007","journal-title":"Am Soc Clin Oncol"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1412"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20564"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60983-0"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.477"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601154"},{"key":"e_1_2_4_9_2","first-page":"791","article-title":"New definition of low\u2010risk neuroblastoma using stage, age, and 1p and MYCN status","volume":"26","author":"Simon T","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)92834-7"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(20001201)35:6<683::AID-MPO43>3.0.CO;2-F"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20536"},{"key":"e_1_2_4_13_2","first-page":"467","article-title":"Metastasi di neuroblastoma alla falce cerebrale. Presentazione di un caso","volume":"83","author":"Brunetti A","year":"1992","journal-title":"Radiol Med"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950240408"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200411000-00003"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000212970.06125.8e"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2005.11.003"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1537"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.582"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.183"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.22243","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.22243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T23:12:09Z","timestamp":1697670729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.22243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,26]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,12,15]]}},"alternative-id":["10.1002\/pbc.22243"],"URL":"https:\/\/doi.org\/10.1002\/pbc.22243","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,26]]}}}